Chai Discovery, an AI company developing a computer-aided design suite for molecules, is collaborating with Novartis to advance the discovery of therapeutic antibodies using AI Under the collaboration ...

Beckman Coulter Diagnostics, a specialist in clinical diagnostics and a Danaher company, has received CE Mark under IVDR for its Acess p-Tau217 assay, a blood test designed to support the clinical ...

AdJane, a clinical-stage vaccine platform company developing intranasal and intramuscular vaccines based on native Outer Membrane Vesicles (nOMVs), has published first-in-human Phase I clinical data ...

Some diseases are more unkind than others. Cystic fibrosis, an inherited disorder often inflicting the young, causes severe damage to the lungs, digestive system and other organs in the body (Clinic, ...

Tau is a microtubule‑associated protein with N‑terminal, proline‑rich, microtubule‑binding, and C‑terminal domains, where the microtubule‑binding region mediates microtubule interaction; alternative ...

AbbVie has shared its topline results from the Phase 3 EPCORE DLBCL-4 trial evaluating the combination of epcoritamab, a T-cell-engaging bispecific antibody, and lenalidomide, compared to rituximab ...

Endotoxin, a lipopolysaccharide (LPS) originating from the outer membrane of Gram-negative bacteria, remains one of the most prevalent and challenging contaminants in recombinant protein preparations ...

Global provider of laboratory automation and solutions Tecan has integrated Agentic AI capabilities into its lab analytics platform Introspect, creating the NVIDIA BioNeMo Agent Toolkit. The NVIDIA ...

Combotope Therapeutics, a biotechnology company discovering tumour-selective antibodies against cancer-specific glycan-protein targets, has formed a strategic research collaboration with Boehringer ...

Measuring liquid flow rate has traditionally been served by devices such as volumetric flow meters, despite their limitations. Based on the principle of heat dispersion, Biotech Liquid Flow Meters ...

Faculty, the developer of the Decision Intelligence platform Faculty Frontier, is launching the Frontier Life Science Developer Studio, a purpose-built environment with the latest tooling to configure ...

Independent European studies presented at the Clinical Trials on Alzheimer’s Disease (CTAD) 2025 and Alzheimer’s & Parkinson’s Disease Conference (ADPD) 2026 confirmed that the HISCL p-Tau217 RUO and ...